文献速递艾滋病与性传播感染

启动抗逆转录病毒治疗后肥胖常见且受传统及HIV/ART特异性危险因素影响

Obesity following ART initiation is common and influenced by both traditional and HIV-/ART-specific risk factors.
PubMed 文献 · J Antimicrob Chemother · 2018-01-01

在巴西里约热内卢的HIV感染成人队列中,回顾性分析2000至2015年启动ART者,基线肥胖率7.9%,随访者中18.3%发生肥胖,发病率为37.4/1000人年;以INSTI为主要核心药物者肥胖风险最高(校正HR 7.12,P<0.0001),其他危险因素包括年轻、女性、基线BMI高、基线CD4+低、基线HIV-1 RNA高、高血压和糖尿病。

要点

  • 启动ART后肥胖常见,随访者肥胖发病率37.4/1000人年。
  • 以INSTI为主要核心药物者肥胖风险最高(校正HR 7.12,P<0.0001)。
  • 女性、HIV疾病严重度及INSTI使用是肥胖关键危险因素。

核心结论

  • 启动ART后肥胖在HIV感染成人中常见,关键危险因素包括女性、HIV疾病严重度和INSTI使用,需进一步研究INSTI与肥胖发生的关联。

研究设计与样本

  • 回顾性分析2000至2015年在巴西里约热内卢启动ART的HIV感染成人,基线分析n=1794,纵向随访n=1567(基线非肥胖且ART暴露≥90天)。

主要发现

  • 基线时7.9%为肥胖,61.3%为男性,48.3%为白人。
  • 纵向随访者中66.2%主要使用NNRTI,32.9%使用PI,0.9%使用INSTI;18.3%发生肥胖,发病率为37.4/1000人年。
  • 多变量分析中,以INSTI为主要ART核心药物者发生肥胖的风险最高(校正HR 7.12,P<0.0001)。
  • 其他危险因素包括较年轻年龄、女性、较高基线BMI、较低基线CD4+ T淋巴细胞计数、较高基线HIV-1 RNA、高血压和糖尿病。

局限性

  • 需进一步研究INSTI与肥胖发生之间的关联。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Obesity rates are increasing among HIV-infected individuals, but risk factors for obesity development on ART remain unclear. OBJECTIVES: In a cohort of HIV-infected adults in Rio de Janeiro, Brazil, we aimed to determine obesity rates before and after ART initiation and to analyse risk factors for obesity on ART. METHODS: We retrospectively analysed data from individuals initiating ART between 2000 and 2015. BMI was calculated at baseline (time of ART initiation). Participants who were non-obese at baseline and had ≥90 days of ART exposure were followed until the development of obesity or the end of follow-up. Obesity incidence rates were estimated using Poisson regression models and risk factors were assessed using Cox regression models. RESULTS: Of participants analysed at baseline (n = 1794), 61.3% were male, 48.3% were white and 7.9% were obese. Among participants followed longitudinally (n = 1567), 66.2% primarily used an NNRTI, 32.9% a PI and 0.9% an integrase strand transfer inhibitor (INSTI); 18.3% developed obesity and obesity incidence was 37.4 per 1000 person-years. In multivariable analysis, the greatest risk factor for developing obesity was the use of an INSTI as the primary ART core drug (adjusted HR 7.12, P < 0.0001); other risk factors included younger age, female sex, higher baseline BMI, lower baseline CD4+ T lymphocyte count, higher baseline HIV-1 RNA, hypertension and diabetes mellitus. CONCLUSIONS: Obesity following ART initiation is frequent among HIV-infected adults. Key risk factors include female sex, HIV disease severity and INSTI use. Further research regarding the association between INSTIs and the development of obesity is needed.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. Bakal DR, Coelho LE, Luz PM, et al. Obesity following ART initiation is common and influenced by both traditional and HIV-/ART-specific risk factors. J Antimicrob Chemother. 2018. PMID: 29722811. doi:10.1093/jac/dky145

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。